Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 10 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ADRA2A
💬1. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬1. ADRA2A
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬1. ADRA2A
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
ADRA2B
💬2. ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬2. ADRA2B
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬2. ADRA2B
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
ADRA2C
💬3. ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬3. ADRA2C
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬3. ADRA2C
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
EDNRA
💬4. EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligan ... | Bosentan
Bosentan
💬4. EDNRA
| Bosentan | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬4. EDNRA
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
EDNRA
💬5. EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligan ... | Bosentan
Bosentan
💬5. EDNRA
| Bosentan | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬5. EDNRA
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
EDNRB
💬6. EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Bosentan
Bosentan
💬6. EDNRB
| Bosentan | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬6. EDNRB
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
EDNRB
💬7. EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Bosentan
Bosentan
💬7. EDNRB
| Bosentan | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬7. EDNRB
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
THRA
💬8. THRA
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway | Liothyronine
Liothyronine
💬8. THRA
| Liothyronine | 4件: 13 13, 78, 210, 212 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
THRB
💬9. THRB
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway | Liothyronine
Liothyronine
💬9. THRB
| Liothyronine | 4件: 13 13, 78, 210, 212 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
PDE5A
💬10. PDE5A
| 3件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway | Sildenafil
Sildenafil
💬10. PDE5A
| Sildenafil | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬10. PDE5A
|